Mackenzie Financial Corp Durect Corp Transaction History

Mackenzie Financial Corp

  • $66.8 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 10, 2022
SELL
$0.38 - $0.64 $4,723 - $7,954
-12,429 Closed
0 $0
Q4 2021

Feb 14, 2022
SELL
$0.9 - $1.31 $745 - $1,084
-828 Reduced 6.25%
12,429 $12,000
Q3 2021

Nov 08, 2021
BUY
$1.21 - $1.61 $16,040 - $21,343
13,257 New
13,257 $17,000

Others Institutions Holding DRRX

# of Institutions
3
Shares Held
593K
Call Options Held
0
Put Options Held
0
View Full List

About DURECT CORP

DRRX Quotes by TradingView
  • Ticker DRRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 227,794,000
  • Market Cap $212M
  • Description
  • DURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and pharmaceutical programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. It also develops larsucosterol (DUR-928), an endogeno...
More about DRRX
Track This Portfolio

Track Mackenzie Financial Corp Portfolio

Follow Mackenzie Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mackenzie Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Mackenzie Financial Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email